Sheng Wu focuses on China-related mergers and acquisitions and M&A involving regulated entities. He represents Chinese and foreign clients in cross-border acquisitions into China (by foreign investors) and outside China (by Chinese investors).

He also routinely advises investors and companies on investment opportunities relating to healthcare insurance. Sheng is also familiar with OTC derivatives and structured products.